Can online meetings company Zoom continue to thrive after the world has access to a COVID-19 vaccine? Rishi Jaluria, the D.A. Davidson Institutional Research Analyst who covers Zoom and other software companies, believes the company has staying power and that remote offices are likely to become a more normalized part of working world landscape. Jaluria digs into the company’s outlook in “Zoom’s growth will likely be sustainable even after a Covid vaccine: D.A. Davidson analyst,” an interview on CNBC’s “Closing Bell” program.
Watch the full interview here.